High Levels of Antidrug Antibodies Against Atezolizumab as a Predictive Marker for Clinical Outcomes in Patients With Hepatocellular Carcinoma
High Levels of Antidrug Antibodies Against Atezolizumab as a Predictive Marker for Clinical Outcomes in Patients With Hepatocellular Carcinoma
复制标题
高水平的 Atezolizumab 抗药抗体作为肝细胞癌患者临床结果的预测标志物
DOI：
10.1001/jamaoncol.2023.0108
复制
发表时间：
2023
期刊：
影响因子：
28.4
通讯作者：
Inamura Kentaro
中科院分区：
文献类型：
--
作者：
Shigematsu Yasuyuki;Inamura Kentaro
